These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37568795)

  • 21. A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS).
    Li S; Miyamoto C; Wang B; Giaddui T; Micaily B; Hollander A; Weiss SE; Weaver M
    Med Phys; 2021 Apr; 48(4):2038-2049. PubMed ID: 33590493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases.
    Mehta N; Zavitsanos PJ; Moldovan K; Oyelese A; Fridley JS; Gokaslan Z; Kinsella TJ; Hepel JT
    Adv Radiat Oncol; 2018; 3(3):245-251. PubMed ID: 30202794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer.
    Oermann EK; Suy S; Hanscom HN; Kim JS; Lei S; Yu X; Zhang G; Ennis B; Rohan JP; Piel N; Sherer BA; Borum D; Chen VJ; Batipps GP; Constantinople NL; Dejter SW; Bandi G; Pahira J; McGeagh KG; Adams-Campbell L; Jha R; Dawson NA; Collins BT; Dritschilo A; Lynch JH; Collins SP
    J Hematol Oncol; 2011 Mar; 4():12. PubMed ID: 21439088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inoperable Pulmonary Carcinoid Tumors: Local Control Rates With Stereotactic Body Radiotherapy/Hypofractionated RT With Image-Guided Radiotherapy.
    Singh D; Chen Y; Cummings MA; Milano MT
    Clin Lung Cancer; 2019 May; 20(3):e284-e290. PubMed ID: 30850224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
    Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG; Steuer CE; Owonikoko TK; Ramalingam SS; Bradley JD; Curran WJ
    J Thorac Oncol; 2017 Nov; 12(11):1687-1695. PubMed ID: 28919394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
    Snyder JE; Willett AB; Sun W; Kim Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
    Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
    Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional normal lung tissue density changes in patients treated with stereotactic body radiation therapy for lung tumors.
    Diot Q; Kavanagh B; Schefter T; Gaspar L; Stuhr K; Miften M
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1024-30. PubMed ID: 22583607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis.
    Tchelebi LT; Lehrer EJ; Trifiletti DM; Sharma NK; Gusani NJ; Crane CH; Zaorsky NG
    Cancer; 2020 May; 126(10):2120-2131. PubMed ID: 32125712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
    Song CW; Glatstein E; Marks LB; Emami B; Grimm J; Sperduto PW; Kim MS; Hui S; Dusenbery KE; Cho LC
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):21-34. PubMed ID: 30836165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myositis following spine radiosurgery for metastatic disease: a case series.
    Lockney DT; Jia AY; Lis E; Lockney NA; Liu C; Hopkins B; Higginson DS; Yamada Y; Laufer I; Bilsky M; Schmitt AM
    J Neurosurg Spine; 2018 Apr; 28(4):416-421. PubMed ID: 29372858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016-2018.
    Gillespie EF; Lapen K; Wang DG; Wijetunga N; Pastrana GL; Kollmeier MA; Yamada J; Schmitt AM; Higginson DS; Vaynrub M; Santos Martin E; Xu AJ; Tsai C; Yerramilli D; Cahlon O; Yang T
    Clin Transl Radiat Oncol; 2020 Nov; 25():75-80. PubMed ID: 33102818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-Dose Hypersensitive Response for Residual pATM and γH2AX Foci in Normal Fibroblasts of Cancer Patients.
    Słonina D; Kowalczyk A; Janecka-Widła A; Kabat D; Szatkowski W; Biesaga B
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):756-766. PubMed ID: 29248168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I/II Study of Extreme Hypofractionated Stereotactic Body Radiation Therapy Boost to Prostate for Locally Advanced, Node-Positive and Oligometastatic Cancer.
    Narang K; Kadian M; Venkatesan K; Mishra S; Bisht S; Gupta D; Banerjee S; Kataria T
    Cureus; 2020 Nov; 12(11):e11751. PubMed ID: 33403181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiobiological basis of SBRT and SRS.
    Song CW; Kim MS; Cho LC; Dusenbery K; Sperduto PW
    Int J Clin Oncol; 2014 Aug; 19(4):570-8. PubMed ID: 24993673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison.
    Dahbi Z; Fadila K; Vinh-Hung V
    Cureus; 2023 Apr; 15(4):e37235. PubMed ID: 37038382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    Wang X; Zamdborg L; Ye H; Grills IS; Yan D
    BMC Cancer; 2018 Oct; 18(1):962. PubMed ID: 30305131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach.
    Gill B; Oermann E; Ju A; Suy S; Yu X; Rabin J; Kalhorn C; Nair MN; Voyadzis JM; Unger K; Collins SP; Harter KW; Collins BT
    Front Oncol; 2012; 2():39. PubMed ID: 22645718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase 1 Study of Stereotactic Body Radiation Therapy Dose Escalation for Borderline Resectable Pancreatic Cancer After Modified FOLFIRINOX (NCT01446458).
    Shaib WL; Hawk N; Cassidy RJ; Chen Z; Zhang C; Brutcher E; Kooby D; Maithel SK; Sarmiento JM; Landry J; El-Rayes BF
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):296-303. PubMed ID: 27475674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.